PATENT CLAIM ANALYSIS

Application Number: 15762497
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "017900"]

Abstract:
Disclosed herein are methods and compositions for increasing and decreasing the permeability of the blood brain barrier for the treatment of diseases and conditions and to facilitate the delivery of agents to the brain, as well as methods and compositions for promoting re-myelination and preventing de-myelination. Compositions include RGMa, soluble RGMa, and functional fragments and variants thereof, RGMc, soluble RGMc, and functional fragments and variants thereof, and Neogenin peptides including 4Ig.

Claim (Index 82):
The method of  claim 76  for treating a disease or condition, wherein the disease or condition is multiple sclerosis (MS), ischemia (stroke), spinal cord injury, Alzheimer's disease, Parkinson's disease, brain cancer, epilepsy, depression, or an ocular condition, including glaucoma or retinitis pigmentosa (RP).

Metadata:
- Claim Count in Document: 59.0
- Percentile: 90.0
- Lexical Diversity: 1.86047
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15136160', '13073275', '13714238', '15569382', '13877356']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7825065532973838
- 35 USC 102 Novelty (BERT): 0.5268322907668459
- Combined Prediction Score: 0.75693912704433
- Mean Citation Score: 300.213026
- Max Citation Score: 326.6331
- Similarity Product: 205.4207024797797

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test